Skip to content

Platform
- Overview
- Publications and Presentations
Pipeline
- Overview
- Clinical Trials
About Us
Careers
News
Contact

Platform
- Overview
- Publications and Presentations
Pipeline
- Overview
- Clinical Trials
About Us
Careers
News
Contact

News

Read the latest news about our company.
To learn more about our research, visit our publications page.

See our publications

Year
Media Type
Search

September 16, 2024 | Media Coverage

Nature Reviews Drug Discovery: In vivo CAR T cells move into clinical trials

September 12, 2024 | Media Coverage

Cell & Gene: The Future Of Autologous CAR-T Manufacturing: Balancing Innovation With Improvement

August 7, 2024 | Media Coverage

Philadelphia Business Journal: Penn spinout Interius BioTherapeutics raises $67M

July 31, 2024 | Media Coverage

ApexOnco: Umoja and AbbVie chase Interius with in vivo Car-T

July 25, 2024 | Media Coverage

Cell & Gene: Manufacturing CAR-T In Vivo

July 15, 2024 | Media Coverage

ApexOnco: In vivo Car-T heads for the clinic, but it’s not Sana’s

1 234 5...»

Platform
- Overview
- Publications and Presentations
Pipeline
- Overview
- Clinical Trials
About Us
Careers
News
Contact

Platform
- Overview
- Publications and Presentations
Pipeline
- Overview
- Clinical Trials
About Us
Careers
News
Contact

Science

Platform
Pipeline
INT2104
INT2106
Publications
Clinical Trials

Company

About Us
Leadership
Board of Directors
Careers
Contact
News

Copyright © 2025 Interius BioTherapeutics, Inc. All Rights Reserved.
Interius^® is a registered trademark of Interius BioTherapeutics, Inc.

Accessibility
Cookies Notice
Privacy Notice
Terms of Use

Interius is now part of Kite, a Gilead Company.

We are singularly focused on achieving cures with cell therapy.

Learn More About Kite